Results 131 to 140 of about 7,220 (213)

Literature Review: Recent Therapeutic Advances in The Management of Prurigo Nodularis: From Conventional Therapy to Biologics and Targeted Small-Molecule Agents. [PDF]

Clin Cosmet Investig Dermatol
Avriyanti E, Larasati R, Rengasamy S, Hidayah RMN, Tsaqilah L, Pangastuti M, Maharani RH.   +6 more
europepmc   +1 more source

Clinical Trial Comparison of Dupilumab and Nemolizumab for Prurigo Nodularis FDA-Approved Biologic Therapy Selection in Prurigo Nodularis. [PDF]

Clin Drug Investig
Robertson A, Rohan C.
europepmc   +1 more source

Comprehensive Transcriptomic Profiling of Nonatopic Prurigo Nodularis in Korean Patients Reveals Il-22-driven Epidermal Stress and Neuro-immuno-fibrotic Remodelling. [PDF]

Acta Derm Venereol
Kim HS, Kim YS, Yosipovitch G.
europepmc   +1 more source

The skin as a sentinel organ for neurodegeneration: An underrecognized target for dementia prevention. [PDF]

Intractable Rare Dis Res
Han Y, Zhou C, Wang P, Karako K, Song P.
europepmc   +1 more source

Rapid itch relief with the biologic agent nemolizumab in Atopic dermatitis and Prurigo nodularis: Promise, complexity and clinical implications. [PDF]

J Eur Acad Dermatol Venereol
Lukaschek K, Weisshaar E.
europepmc   +1 more source

Systemic inflammatory indicators and their clinical correlations in prurigo nodularis: A multicenter cross-sectional study in China. [PDF]

JAAD Int
Mai X, Wu J, Huang H, Liao Y, Yin M, Wei L, Yang C, Zhang J, Dou X.   +8 more
europepmc   +1 more source

Prurigo pigmentosa in patient with diabetes on SGLT2 inhibitor. [PDF]

JAAD Case Rep
Khan T, Hirsch Y, McGivney R, Hoyer S.
europepmc   +1 more source

Targeting type 2 inflammation in dermatology: mechanisms and clinical implications. [PDF]

Front Immunol
Khalil N, Farhadi L, Yosipovitch G.
europepmc   +1 more source

Acute T-cell leukemia/lymphoma presenting with leukemia cutis mimicking prurigo nodularis. [PDF]

JAAD Case Rep
Elghannam M, Osto M, Strong J, Driscoll M.   +3 more
europepmc   +1 more source

Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria. [PDF]

Dermatol Ther (Heidelb)
Yosipovitch G, Kim BS, Koo JY, Chen Z, Wiggins S, Zahn J, Sugerman P, Haddad EB, Cyr SL.   +8 more
europepmc   +1 more source